Solesence, Inc. (NASDAQ:SLSN – Get Free Report)’s share price was down 7.4% during trading on Thursday . The stock traded as low as $1.18 and last traded at $1.26. Approximately 29,206 shares traded hands during trading, a decline of 36% from the average daily volume of 45,331 shares. The stock had previously closed at $1.36.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reissued a “sell (d)” rating on shares of Solesence in a research report on Friday, March 27th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has a consensus rating of “Sell”.
Check Out Our Latest Analysis on SLSN
Solesence Trading Down 1.2%
Solesence (NASDAQ:SLSN – Get Free Report) last posted its quarterly earnings results on Tuesday, May 12th. The company reported ($0.01) earnings per share (EPS) for the quarter. The company had revenue of $12.96 million during the quarter. Solesence had a return on equity of 5.39% and a net margin of 1.56%.
Institutional Investors Weigh In On Solesence
Large investors have recently bought and sold shares of the business. Bank of America Corp DE bought a new stake in Solesence in the 2nd quarter worth about $26,000. Goldman Sachs Group Inc. bought a new stake in Solesence in the 4th quarter worth about $30,000. JPMorgan Chase & Co. bought a new stake in Solesence in the 2nd quarter worth about $39,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of Solesence during the 2nd quarter valued at about $45,000. Finally, Jane Street Group LLC grew its stake in shares of Solesence by 170.6% during the 4th quarter. Jane Street Group LLC now owns 39,056 shares of the company’s stock valued at $62,000 after purchasing an additional 24,625 shares during the period. 70.22% of the stock is currently owned by institutional investors.
About Solesence
Nanophase Technologies Corporation provides engineered materials, formulation development, and commercial manufacturing with an integrated family of technologies in the United States. It offers surface engineered zinc oxide and titanium dioxide for sunscreens and personal care products; fully formulated cosmetics, sun care, and skin care under the Solésence brand name; and advanced materials products, such as architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and various surface finishing technologies applications.
Featured Stories
- Five stocks we like better than Solesence
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Receive News & Ratings for Solesence Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solesence and related companies with MarketBeat.com's FREE daily email newsletter.
